Capital Research Global Investors Takeda Pharmaceutical CO LTD Put Options Transaction History
Capital Research Global Investors
- $466 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TAK
# of Institutions
338Shares Held
68.6MCall Options Held
1.72MPut Options Held
178K-
Morgan Stanley New York, NY5.6MShares$77.6 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.63MShares$64.1 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.22MShares$58.4 Million0.05% of portfolio
-
First Trust Advisors LP Wheaton, IL3.24MShares$44.9 Million0.04% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.08MShares$42.7 Million0.06% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $43.1B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...